Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/44248, first published .
Artificial Intelligence for the Prediction and Early Diagnosis of Pancreatic Cancer: Scoping Review

Artificial Intelligence for the Prediction and Early Diagnosis of Pancreatic Cancer: Scoping Review

Artificial Intelligence for the Prediction and Early Diagnosis of Pancreatic Cancer: Scoping Review

Journals

  1. Badidi E. Edge AI for Early Detection of Chronic Diseases and the Spread of Infectious Diseases: Opportunities, Challenges, and Future Directions. Future Internet 2023;15(11):370 View
  2. 吴 冠. To Compare the Stability of Different Clinical Model Frameworks in the Overall Survival Rate and Specific Survival Rate of Patients with Non-Metastatic Pancreatic Head Cancer, Pancreatic Body Cancer and Pancreatic Tail Cancer Based on Machine Learning. Advances in Clinical Medicine 2023;13(11):18150 View
  3. Mohammad N, Huguenin A, Lefebvre A, Menvielle L, Toubas D, Ranque S, Villena I, Tannier X, Normand A, Piarroux R. Nosocomial transmission ofAspergillus flavusin a neonatal intensive care unit: Long-term persistence in environment and interest of MALDI–ToF mass-spectrometry coupled with convolutional neural network for rapid clone recognition. Medical Mycology 2024;62(1) View
  4. Dodda K, Muneeswari G. IANFIS: a machine learning–based optimized technique for the classification and segmentation of pancreatic cancer. Research on Biomedical Engineering 2024;40(2):373 View
  5. Zadeh Shirazi A, Tofighi M, Gharavi A, Gomez G. The Application of Artificial Intelligence to Cancer Research: A Comprehensive Guide. Technology in Cancer Research & Treatment 2024;23 View
  6. Liu W, Zhang B, Liu T, Jiang J, Liu Y. Artificial Intelligence in Pancreatic Image Analysis: A Review. Sensors 2024;24(14):4749 View
  7. Conforti I, Benzi A, Caffa I, Bruzzone S, Nencioni A, Marra A. New Analogues of the Nicotinamide Phosphoribosyltransferase Inhibitor FK866 as Potential Anti-Pancreatic Cancer Agents. Medicinal Chemistry 2024;20(7):694 View
  8. Shirzad M, Salahvarzi A, Razzaq S, Javid-Naderi M, Rahdar A, Fathi-karkan S, Ghadami A, Kharaba Z, Romanholo Ferreira L. Revolutionizing prostate cancer therapy: Artificial intelligence – Based nanocarriers for precision diagnosis and treatment. Critical Reviews in Oncology/Hematology 2025;208:104653 View
  9. Xu H, Gong T, Song X, Chen Q, Bao Q, Yao W, Xie M, Li C, Grzegorzek M, Shi Y, Sun H, Li X, Zhao Y, Gao S, Wu Q. Artificial Intelligence Performance in Image-Based Cancer Identification: Umbrella Review of Systematic Reviews. Journal of Medical Internet Research 2025;27:e53567 View

Conference Proceedings

  1. Topalov V, Kostadinov R, Vicheva D, Paunov L, Georgieva M, Papazova M. 2023 International Conference on Applied Mathematics & Computer Science (ICAMCS). The Primary Healthcare Providers’ Attitudes towards Artificial Intelligence and Information Communication Technologies Implementation into Pancreatic Cancer Risk Prediction, Prevention and Early Diagnosis View
  2. Nicolăescu C, Enescu F, Bizon N. 2024 16th International Conference on Electronics, Computers and Artificial Intelligence (ECAI). Designing of Medical Diagnostic System based on Blockchain and Artificial Intelligence Technologies View